EOSINOPHILIC GASTROENTERITIS
Clinical trials for EOSINOPHILIC GASTROENTERITIS explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GASTROENTERITIS trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare stomach disease
Disease control CompletedThis study tested a drug called CC-93538 in 48 Japanese adults and teenagers with eosinophilic gastroenteritis, a condition where certain white blood cells build up in the stomach and intestines, causing pain and other symptoms. The goal was to see if the drug could reduce these …
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for stomach inflammation: drug targets rare disease
Disease control CompletedThis study tested a drug called dupilumab in 41 people aged 12 to 70 with eosinophilic gastritis, a condition where too many immune cells cause stomach inflammation. Participants received either the drug or a placebo as injections every two weeks for 12 weeks, with an option to c…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Nausea drug may ease colonoscopy prep for children
Symptom relief CompletedThis study tested whether ondansetron, a common nausea medicine, helps children aged 2 to 20 tolerate the bowel preparation needed before a colonoscopy. Researchers measured how clean the bowel was and how much pain, bloating, nausea, and vomiting the children felt. The goal was …
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE4 • Sponsor: State University of New York - Downstate Medical Center • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC